Dr. Reddy's Laboratories gets EIR from USFDA for API manufacturing plant in New York

10 Feb 2022 Evaluate

Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA), for API manufacturing plant at Middleburg, New York, indicating closure of the audit and the inspection classification of this facility is determined as ‘Voluntary action indicated’ (VAI). Currently, the company does not have any sales from this plant.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas. 

Dr. Reddys Lab Share Price

1258.55 -15.70 (-1.23%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.